AtaiBeckley (XTER:B72) Profitability Rank: 0 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:B72 AtaiBeckley Inc XTER:B72
58 GF Score
Price €6.20
GF Value €8.03
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is AtaiBeckley Profitability Rank?

AtaiBeckley has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is rated on a scale of 1 to 10 and is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

AtaiBeckley's Operating Margin % for the quarter that ended in Jun. 2026 was -2,448.61%. As of today, AtaiBeckley's Piotroski F-Score is 4.


AtaiBeckley Profitability Rank Related Terms


XTER:B72 vs NRIX, SLS, VRDN: Profitability Rank Comparison

For the Biotechnology subindustry, AtaiBeckley's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtaiBeckley Profitability Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AtaiBeckley's Profitability Rank distribution charts can be found below:

* The bar in red indicates where AtaiBeckley's Profitability Rank falls into.


XTER:B72
58GF Score
AtaiBeckley Inc XTER:B72
Profitability Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtaiBeckley Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The rank is rated on a scale of 1 to 10. A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

AtaiBeckley has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

AtaiBeckley's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2026 ) / Revenue (Q: Jun. 2026 )
=-36.215 / 1.479
=-2,448.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

AtaiBeckley has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank

Is AtaiBeckley (XTER:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €6.20 is trading 22.8% below its estimated GF Value™ of €8.03. GuruFocus considers AtaiBeckley to be Modestly Undervalued.

Key valuation signals for XTER:B72:

  • Profitability Rank: 0
  • GF Value™: €8.03 vs. price of €6.20 (22.8% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the XTER:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtaiBeckley Business Description

Other Exchanges ATAI:USA
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
58GF Score

Get the complete analysis for XTER:B72

Profitability Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.20
Price
€8.03
GF Value